Gritstone Oncology, Inc.·4

Mar 14, 7:21 PM ET

Rousseau Raphael 4

4 · Gritstone Oncology, Inc. · Filed Mar 14, 2019

Insider Transaction Report

Form 4
Period: 2019-02-13
Rousseau Raphael
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-13+66,00066,000 total
    Exercise: $12.02From: 2019-04-01Exp: 2029-02-12Common Stock (66,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2019.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4